FORESIGHT is transforming drug development by using advanced molecular imaging to track medicines in the body and identify the best treatment for each patient. This innovative approach makes drug development faster, more effective, and more personalized, helping to bring better treatments to those who need them most. UMCG, AUMC, NKI/AVL and TU/e have combined their high-quality expertise and infrastructure in the FORESIGHT Service and Innovation Center. This R&D Center collaborates with (inter)national companies and agencies. Multidisciplinary teams with unique knowledge of tracer development, bioengineering, imaging and data analysis/AI support the teams performing (pre)clinical molecular imaging studies. The FORESIGHT-PPP program can demonstrate the impact of imaging with compelling public-private innovative development projects, thereby accelerating sustainable growth of the Center. By combining strengths in tracer development, bioengineering, imaging, and AI-driven data analysis, FORESIGHT aims to transform drug development and precision medicine.

2025-2032
Prof. Dr. Liesbeth de Vries
UMCG, AUMC, NKI/AvL, TU/e
Website: The FORESIGHT PPP Program